Efficacy and safety of TNF inhibitors - results of randomized controlled clinical trials
Journal Title: Reumatologia - Year 2006, Vol 44, Issue 6
Abstract
TNF inhibitors were first approved for treatment of active rheumatoid arthritis (RA) in 1998. Since that time, a series of multicentre, randomized controlled trials have been evaluated in early and established RA, in patients who had not been treated with methotrexate (Mtx) as well as in those who had an inadequate response to traditional disease modifying antirheumatic drugs (DMARD), including Mtx. In these trials approximately 6000 RA patients have participated. Clinical response to treatment and adverse effects of anti-TNF agents are discussed. The relative expense of TNF inhibitors makes their universal use impractical. The use of TNF inhibitors in the treatment of active RA should be considered when traditional DMARD, including combination therapy of DMARD, are not effective.
Authors and Affiliations
Anna Filipowicz-Sosnowska
Keywords
Related Articles
- EP ID EP149604
- DOI -
- Views 67
- Downloads 0
Usefulness of anti-cyclic citrullinated peptide autoantibodies assays in differential diagnosis of polyarthritis
An early stage of rheumatoid arthritis (RA) has frequently an atypical course and it is difficult to differentiate it from other types of polyarthritis. It has been proved, that anti-cyclic citrullinated peptide antibodi...
Pulmonary-renal syndrome in patients with systemic connective tissue diseases
Pulmonary-renal syndrome (PRS) can originate from several connective tissue diseases. It belongs to the potentially life-threatening conditions. Clinically PRS is a combination of diffuse pulmonary hemorrhage and renal i...
Case report of the patients with rheumatoid arthritis pneumoconiosis, amyloidosis. When we can diagnose Caplan's syndrome
We describe a male patient with pneumoconiosis and diagnosed RA, amyloidosis, nephritic syndrome and renal insufficiency. This particular case report has underlined aggressive progression of RA with rapid involvement of...
Ocena jakości życia pacjentów z reumatoidalnym zapaleniem stawów
Reumatoidalne zapalenie stawów (RZS) jest przewlekłą, zapalną, układową chorobą tkanki łącznej, prowadzącą do niepełnosprawności, inwalidztwa i przedwczesnej śmierci. Przewlekły i okaleczający charakter RZS oraz ogranicz...
First EULAR/EUSTAR Scleroderma Course The assessment of the patient with systemic sclerosis Budapeszt, 13–16 stycznia 2005 r.